Moderna's CMV vaccine shows promise in Long-Term Follow-Up study

NCT ID NCT04975893

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a long-term follow-up of a phase 2 trial testing Moderna's mRNA-1647 vaccine against cytomegalovirus (CMV). It involves 135 adults who previously received the vaccine or a placebo. Researchers are checking how long the immune response lasts and whether a booster dose is safe and effective. The goal is to eventually prevent CMV infection, which can be dangerous for pregnant women and people with weak immune systems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mRNA-1647 vaccine
What this could lead to
If successful, this could support the development of a vaccine to prevent cytomegalovirus (CMV) infection, which can cause serious complications in newborns and people with weakened immune systems.
What could go wrong
This is a small, early-phase extension study focused on long-term immune persistence and safety, not on proving the vaccine prevents infection. The results may not confirm effectiveness, and side effects are still being evaluated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alliance for Multispeciality Research, LLC

    Lexington, Kentucky, 40509, United States

  • Crossroads Clinical Research (Victoria)

    Victoria, Texas, 77901, United States

  • J. Lewis Research, Inc. / Foothill Family Clinic South

    Salt Lake City, Utah, 84109, United States

  • J. Lewis Research, Inc. / Foothill Family Clinic South

    Salt Lake City, Utah, 84121, United States

  • Johnson County Clin-Trials, Inc.

    Lenexa, Kansas, 66219, United States

  • Optimal Research, LLC

    Peoria, Illinois, 61610, United States

  • Tekton Research Inc

    Austin, Texas, 78745, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.